Login
$RNAC
$6.46 +$0.18 (2.87%) Close

$RNAC 8-K/A SEC Filings

Filed On Filing
23 Jan 2024 8-K/A: Financial Statements and Exhibits

On November 13, 2023, Selecta Biosciences, Inc., a Delaware corporation (“Selecta”), acquired Cartesian Therapeutics, Inc., a Delaware corporation (“Old Cartesian”), in accordance with the terms of an Agreement and Plan of Merger, dated ...

14 Feb 2017 8-K/A: Financial Statements and Exhibits
14 Dec 2016 8-K/A: Other Events

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support